Abstract:Chronic obstructive pulmonary disease (COPD) and lung cancer represent formidable challenges in global health, characterized by intricate pathophysiological mechanisms and multifaceted disease progression. This comprehensive review integrates insights from diverse perspectives to elucidate the intricate roles of long non-coding RNAs (lncRNAs) in the pathogenesis of COPD and lung cancer, focusing on their diagnostic, prognostic, and therapeutic implications. In the context of COPD, dysregulated lncRNAs, such as NEAT1, TUG1, MALAT1, HOTAIR, and GAS5, emerge as pivotal regulators of genes involved in the disease pathogenesis and progression. Their identification, profiling, and correlation with the disease severity present promising avenues for prognostic and diagnostic applications, thereby shaping personalized disease interventions. These lncRNAs are also implicated in lung cancer, underscoring their multifaceted roles and therapeutic potential across both diseases. In the domain of lung cancer, lncRNAs play intricate modulatory roles in disease progression, offering avenues for innovative therapeutic approaches and prognostic indicators. LncRNA-mediated immune responses have been shown to drive lung cancer progression by modulating the tumor microenvironment, influencing immune cell infiltration, and altering cytokine production. Their dysregulation significantly contributes to tumor growth, metastasis, and chemo-resistance, thereby emphasizing their significance as therapeutic targets and prognostic markers. This review summarizes the transformative potential of lncRNA-based diagnostics and therapeutics for COPD and lung cancer, offering valuable insights into future research directions for clinical translation and therapeutic development.

Crosstalk between lncRNAs and Wnt/β-catenin signaling pathways in lung cancers: From cancer progression to therapeutic response

The oncogenic potentials and diagnostic significance of long non-coding RNA LINC00310 in breast cancer.

Wnt/β-catenin signaling in the development and therapeutic resistance of non-small cell lung cancer

Exosomal LncRNAs and CircRNAs in lung cancer: Emerging regulators and potential therapeutic targets

The Emerging Role and Promise of Long Noncoding RNAs in Lung Cancer Treatment

Role of Cytoplasmic Lncrnas in Regulating Cancer Signaling Pathways

LncRNAs in non-small cell lung cancer: novel diagnostic and prognostic biomarkers

Exosomal Long Non-Coding RNAs: Biological Properties and Therapeutic Potential in Cancer Treatment

WNT ligands in non-small cell lung cancer: from pathogenesis to clinical practice

Role of the lncRNA/Wnt signaling pathway in digestive system cancer: a literature review

Long Non-Coding RNA in the Pathogenesis of Cancers

Comprehensive landscape and future perspective of long noncoding RNAs in non-small cell lung cancer: it takes a village

Recent progress of exosomal lncRNA/circRNA–miRNA–mRNA axis in lung cancer: implication for clinical application

Critical roles of the lncRNA CASC11 in tumor progression and cancer metastasis: The biomarker and therapeutic target potential

Long Non-Coding Rnas in Non-Small Cell Lung Cancer As Biomarkers and Therapeutic Targets

Unveiling Prognostic and Diagnostic Power and Their Driving Role in Lung Cancer Progression

LncRNA in tumorigenesis of non-small-cell lung cancer: From bench to bedside

lncRNA and breast cancer: Progress from identifying mechanisms to challenges and opportunities of clinical treatment

LncRNAs as nodes for the cross-talk between autophagy and Wnt signaling in pancreatic cancer drug resistance

Non-coding RNAs in Lung Cancer: Emerging Regulators of Angiogenesis

Long Non-Coding RNAs in Lung Cancer: The Role in Tumor Microenvironment